Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Sanofi | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Sanofi

Revenues up 16% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi

2Q Revenues: €9.4 billion (+16%)

2Q Earnings: €1.8 billion (+20%)

YTD Revenues: €18.2 billion (+14%)

YTD Earnings: €3.6 billion (+16%)

Comments: Diabetes sales neared €2.0 billion in the quarter, up 11% driven by Lantus sales of €1.7 billion, up 10%. Genzyme sales were €907, up 41%. Plavix sales were €545 million, up 28%. Lovenox sales were €433 milion, up 3% Renagel/Renvela sales were up 69% to €231 million. Aprovel sales were €224 million, up 16%. Oncology sales were up 16% to €390 million driven by Aubagio (up 110% to €204 million) and Lemtrada (up 833% to $56 million), as well as Cerezyme, Myozyme, and Fabrazine, up 14%, 24%, and 19%, respectively.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics